3rd Quarter - Report

BGR GOVERNMENT AFFAIRS for AMGEN INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Provide advice and strategic counsel with regard to regulations that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Care Reform, Medicaid, 340b, FDA regulatory issues, and corporate tax reform.

LobbyistCovered position, as disclosed
DAVID BOYER See prior filing
BRENT ALAN DEL MONTE See prior filing
RYAN LONG See prior filing
DANIEL R MURPHY COS Sec of HUD
ROBERT WOOD See prior filing

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.